N
RPID icon

Nuveen’s Rapid Micro Biosystems RPID Stock Holding History

Nuveen’s Portfolio RPID Stock Details RPID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,324
Closed -$171K – 3450
2022
Q1 		$171K Buy
22,324
+11,518
+107% +$84.8K ﹤0.01% 3214
2021
Q4 		$106K Hold
10,806
– – ﹤0.01% 3281
2021
Q3 		$200K Buy
+10,806
New +$223K ﹤0.01% 3277

Other funds holding RPID

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KLM
Kennedy Lewis Management New York $21.9M AUM 12.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $12.3M AUM 3.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen's RPID Position: Q2 2022 in Review

Nuveen sold out of Rapid Micro Biosystems (RPID) in Q2 2022, closing a stake of 22,324 shares — an estimated $171K sold.

Nuveen first reported a position in RPID in Q3 2021 and held it in 3 quarters. The position peaked at $200K in Q3 2021. 52 funds tracked by Wall St. Rank hold RPID as of Q2 2022.

  • Nuveen reported no remaining Rapid Micro Biosystems position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 22,324 Rapid Micro Biosystems shares in Q2 2022, an estimated $171K.
  • Nuveen first reported a position in Rapid Micro Biosystems in Q3 2021 and held it in 3 quarters.
  • Nuveen's Rapid Micro Biosystems position peaked at $200K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Rapid Micro Biosystems as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.